| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Fernando Aiuti | |
| Ivano Mezzaroma | |||
| P433 | issue | 2 | |
| P304 | page(s) | 88-97 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | AIDS Reviews | Q21042370 |
| P1476 | title | Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART | |
| P478 | volume | 8 |
| Q27314576 | A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy |
| Q35814594 | Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study |
| Q35905907 | Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings |
| Q38405864 | CD4 Decay Rate as an Indicator of the Time Interval between Initial Infection and First Diagnosis among Drug-Naïve Human Immunodeficiency Virus Seropositive Individuals in Lagos, Nigeria |
| Q40536799 | Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir |
| Q40919867 | Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved? |
| Q35873402 | Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients |
| Q35904816 | Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial |
| Q33707759 | Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa |
| Q37276430 | Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India |
| Q34007172 | Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease |
| Q51760002 | HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication. |
| Q47151081 | HIV as a Cause of Immune Activation and Immunosenescence |
| Q34134411 | HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients |
| Q34140484 | HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment |
| Q37438634 | Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART |
| Q33848181 | Human T-Cell Development and Thymic Egress: An Infectious Disease Perspective |
| Q35197395 | IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. |
| Q34351320 | Immune activation and HIV persistence: implications for curative approaches to HIV infection |
| Q40373312 | Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort |
| Q35614736 | Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand |
| Q34963393 | Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment |
| Q34633434 | Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses |
| Q37375957 | Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture |
| Q42233499 | Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rγ(null) mice |
| Q36877987 | Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings |
| Q35082553 | Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease |
| Q39581584 | Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet |
| Q33867181 | Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults |
| Q34100037 | Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease |
| Q38865986 | Relationship between leptin levels and suppressed CD4 counts in HIV patients. |
| Q35988556 | Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype |
| Q34612821 | Role of the Fas/FasL pathway in HIV or SIV disease |
| Q34588220 | Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection |
| Q37021073 | Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance |
| Q35946179 | The role of disease stage, plasma viral load and regulatory T cells (Tregs) on autoantibody production in SIV-infected non-human primates |
| Q36378994 | Translating insights from persistent LCMV infection into anti-HIV immunity |
Search more.